Rchr
J-GLOBAL ID：201901007387115420   Update date: Apr. 03, 2024

Nishikawa Masaki

ニシカワ マサキ | Nishikawa Masaki
Research field  (1)： Biomedical engineering
Research theme for competitive and other funds  (8)：
  • 2022 - 2026 Mathematical Dynamic Modeling of Heterogeneous Liver Cells
  • 2022 - 2025 ヒトiPS細胞の増幅分化における超高密度化・低コスト化の限界
  • 2020 - 2024 移植可能な腎オルガノイドの構築
  • 2021 - 2023 インスタント細胞・組織の開発
  • 2021 - 2023 ヘテロな肝細胞の生理学的役割分担の解明と創薬や医療への応用
Show all
Papers (44)：
  • Benedikt Scheidecker, Stéphane Poulain, Masahiro Sugimoto, Taketomo Kido, Takumi Kawanishi, Atsushi Miyajima, Soo Hyeon Kim, Hiroshi Arakawa, Yukio Kato, Masaki Nishikawa, et al. Dynamic, IPSC-derived hepatic tissue tri-culture system for the evaluation of liver physiology in vitro. Biofabrication. 2024. 16. 2. 025037-025037
  • Shant Nepal, Jinyan Si, Shohei Ishikawa, Masaki Nishikawa, Yasuyuki Sakai, Aya M. Akimoto, Hiroyuki Okada, Shinsuke Ohba, Ung-il Chung, Takamasa Sakai, et al. Injectable phase-separated tetra-armed poly(ethylene glycol) hydrogel scaffold allows sustained release of growth factors to enhance the repair of critical bone defects. Regenerative Therapy. 2024. 25. 24-34
  • Dhimas Agung Kurniawan, Sylvia Leo, Mutsumi Inamatsu, Sohei Funaoka, Taichi Aihara, Mizuno Aiko, Inoue Rei, Takeshi Sakura, Hiroshi Arakawa, Yukio Kato, et al. Gut-liver microphysiological systems revealed potential crosstalk mechanism modulating drug metabolism. PNAS Nexus. 2024
  • Benedikt Scheidecker, Stéphane Poulain, Masahiro Sugimoto, Hiroshi Arakawa, Soo H Kim, Takumi Kawanishi, Yukio Kato, Mathieu Danoy, Masaki Nishikawa, Yasuyuki Sakai. Mechanobiological stimulation in organ-on-a-chip systems reduces hepatic drug metabolic capacity in favor of regenerative specialization. Biotechnology and bioengineering. 2024
  • Tia Utami, Mathieu Danoy, Rubina Rahaman Khadim, Fumiya Tokito, Hiroshi Arakawa, Yukio Kato, Taketomo Kido, Atsushi Miyajima, Masaki Nishikawa, Yasuyuki Sakai. A highly efficient cell culture method using oxygen-permeable PDMS-based honeycomb microwells produces functional liver organoids from human induced pluripotent stem cell-derived carboxypeptidase M liver progenitor cells. Biotechnology and bioengineering. 2024
ｍore...
MISC (7)：
ｍore...
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page

TOP

BOTTOM